Storgatan 11
SE-582 23 Linköping, Sweden
A New Era in Quantitative MRI Begins Now
With SyntheticMR's novel relaxometry technology, enhanced by Combinostics's AI-driven automated MRI quantification.
Experience unmatched precision and efficiency in medical imaging.
Our cutting-edge solutions address a wide range of neurologic disorders, from pediatric to neurodegenerative conditions, leveraging the expertise of Radiology, Neurology, and Nuclear Medicine to maximize patient outcomes.
An AI-driven clinical decision support system enhances differential diagnosis and predicts disease progression in cognitive disorders by combining imaging and clinical data.
The combined solutions provide unique insights into automatically parcellated brain structures and segmented lesions by adding quantitative tissue maps, making it possible to understand the tissue status of a focal volume.
SyntheticMR AB develops and markets innovative software solutions for Magnetic Resonance Imaging (MRI). SyntheticMR AB has developed SyMRI®, delivering multiple, adjustable contrast images and quantitative data from a single 5-minute scan. The SyMRI product is available in different packages. SyMRI NEURO delivers multiple contrast images, tissue segmentations and quantitative data on the brain. SyMRI KNEE and SyMRI SPINE provides multiple contrast images and quantitative data for knee and spine anatomies. SyMRI NEURO is CE-marked and FDA 510(k) cleared and SyMRI KNEE and SyMRI SPINE is CE-marked. SyMRI is a registered trademark in Europe and the USA. SyntheticMR is listed on the Spotlight Stock Market Exchange in Stockholm, Sweden.
